Tybourne Capital Management HK Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Tybourne Capital Management HK Ltd
CRD #164723
SEC #802-76945
CIK #0001553936
AUM
Employees
Phone85239836800
AddressSuites 818822, 8/F, Bank of America Tower
Hong Kong, Hong Kong
Source [IAPD] [EDGAR] [Website]
Total AUM ($)
1.00.80.60.40.20.02010201520212027
Sector Form 13F Holdings Value ($B)
Taysha Gene Therapies Inc 0.0
Tocagen Inc 0.0
Alumis Inc 0.0
Zentalis Pharmaceuticals Inc 0.0
 
 
 
 
 
 
 
Holdings by Sector ($B)
5.04.03.02.01.00.02012201620212026
Type Form D Funds Date Sold AUM
PE TSOF Co-Investment Fund 7 LP 2026-03-30 11.0 M
PE TSOF Co-Investment Fund 6 LP 2025-03-24 11.0 M
HF Westbourne Long Short Master Fund 2024-03-28 83.0 M
PE TSOF Co-Investment Fund 5 LP 2023-03-30
PE TSOF Co-Investment Fund 2 LP 2022-03-28 4.5 M
PE TSOF Co-Investment Fund LP [2022-03-28] 9.1 M
PE Tybourne Strategic Opportunities Fund II LP [2022-03-28] 350.0 M
PE Tybourne Strategic Opportunties Fund LP [2020-03-31] 77.5 M 346.0 M
HF Tybourne Long Opportunities Master Fund [2014-03-31] 12.5 M 939.0 M
HF Tybourne Equity Master Fund [2012-07-18] 243.4 M 2.4 B
View All
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors Role # Filings # Firms 2011 - 2026
Grant Jackson 174 39
Patrick Agemian 111 30
Gregory Link 85 19
James Walker 260 12
Viswanathan Krishnan 6 2
Tanvir Ghani 5 2
Tybourne Capital Management Limited 4 2
Tybourne Capital Management HK Limited 4 2
EDGAR Form CIK 2011 - 2026
13F-HR [0001553936]
3 [0001553936]
4 [0001553936]
SC 13D [0001553936]
SC 13G [0001553936]
Form 13D/13G Filer Form 13D/13G Subject Filed
Tybourne Capital Management HK Ltd Forte Biosciences Inc [2024-02-14]
Tybourne Capital Management HK Ltd Zentalis Pharmaceuticals Inc [2023-02-14]
Tybourne Capital Management HK Ltd Zentalis Pharmaceuticals Inc [2022-02-14]
Tybourne Capital Management HK Ltd TPG Pace Beneficial Finance Corp [2021-04-09]
Tybourne Capital Management HK Ltd Zentalis Pharmaceuticals Inc [2020-05-29]
Tybourne Capital Management HK Ltd Farfetch Ltd [2020-02-14]
Tybourne Capital Management HK Ltd Exicure Inc [2019-08-12]
Tybourne Capital Management HK Ltd Bicycle Therapeutics PLC [2019-06-03]
Tybourne Capital Management HK Ltd Workday Inc [2016-04-01]
Tybourne Capital Management HK Ltd Dunkin' Brands Group Inc [2016-02-16]
View All
Firm Profile (Form ADV)
Fund TypesHedge Fund, Private Equity
LEI549300PW6DL740UUHC85
Form 3/4/5 Subject 2011 - 2026
Tybourne Kesari Ltd
Tybourne Capital Management Ltd
TPG Pace Beneficial Finance Corp.
Krishnan Viswanathan
Tybourne Capital Management HK Ltd
Bicycle Therapeutics PLC
Aquila Investments IV
Boston Beer Co Inc
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com